Commentary

Predicting QoL in Colorectal Cancer Survivors

Publish date: November 19, 2012

 

I couldn’t agree more.

Dr. Freed is a psychologist in Santa Barbara, Calif., and a medical journalist.

Pages

Recommended Reading

Liver Candidates Decline Many Organ Offers
MDedge Internal Medicine
Fatty Liver Disease Cited for Rise in Hepatocellular Carcinoma
MDedge Internal Medicine
Acetaminophen Liver Failure Least Likely to Get Transplant
MDedge Internal Medicine
Benefit of Young Liver Donors Scrutinized in Study
MDedge Internal Medicine
Acetaminophen-Linked Liver Failure Risk Heightened in Bariatric Surgery Patients
MDedge Internal Medicine
Antivirals Linked to Lower Risk of Liver Cancer Return
MDedge Internal Medicine
Kidneys Benefited From Everolimus After Liver Transplant
MDedge Internal Medicine
Gastric Acid Drugs, Antibiotics Tied to Recurrent C. difficile Risk
MDedge Internal Medicine
Panel Calls for More Safety Data for Hepatitis B Vaccine
MDedge Internal Medicine
Investigational HCV Regimens Ditch the Interferon
MDedge Internal Medicine